Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to 0.45%.

  • Bicycle Therapeutics' Return on Invested Capital fell 2300.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 2300.0%. This contributed to the annual value of 0.35% for FY2024, which is 2400.0% up from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Return on Invested Capital is 0.45%, which was down 2300.0% from 0.4% recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Return on Invested Capital high stood at 0.22% for Q3 2024, and its period low was 0.65% during Q2 2023.
  • Its 5-year average for Return on Invested Capital is 0.39%, with a median of 0.41% in 2021.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -3800bps in 2023, then skyrocketed by 3600bps in 2024.
  • Bicycle Therapeutics' Return on Invested Capital (Quarter) stood at 0.25% in 2021, then crashed by -73bps to 0.43% in 2022, then dropped by -11bps to 0.48% in 2023, then soared by 47bps to 0.25% in 2024, then crashed by -78bps to 0.45% in 2025.
  • Its Return on Invested Capital was 0.45% in Q3 2025, compared to 0.4% in Q2 2025 and 0.32% in Q1 2025.